ID   PLCD1_HUMAN             Reviewed;         756 AA.
AC   P51178; B3KR14; Q86VN8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-delta-1;
DE   AltName: Full=Phospholipase C-III;
DE            Short=PLC-III;
DE   AltName: Full=Phospholipase C-delta-1;
DE            Short=PLC-delta-1;
GN   Name=PLCD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Aorta;
RX   PubMed=7890667; DOI=10.1074/jbc.270.10.5495;
RA   Cheng H.F., Jiang M.J., Chen C.L., Liu S.M., Wong L.P., Lomasney J.W.,
RA   King K.;
RT   "Cloning and identification of amino acid residues of human
RT   phospholipase C delta 1 essential for catalysis.";
RL   J. Biol. Chem. 270:5495-5505(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANTS NDNC3 ARG-209 AND THR-574.
RX   PubMed=21665001; DOI=10.1016/j.ajhg.2011.05.014;
RA   Kiuru M., Kurban M., Itoh M., Petukhova L., Shimomura Y., Wajid M.,
RA   Christiano A.M.;
RT   "Hereditary leukonychia, or porcelain nails, resulting from mutations
RT   in PLCD1.";
RL   Am. J. Hum. Genet. 88:839-844(2011).
CC   -!- FUNCTION: The production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is
CC       mediated by activated phosphatidylinositol-specific phospholipase
CC       C enzymes. Essential for trophoblast and placental development.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 3 Ca(2+) ions per subunit. Two of the Ca(2+) ions are
CC       bound to the C2 domain. {ECO:0000250};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51178-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51178-2; Sequence=VSP_042919;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Nail disorder, non-syndromic congenital, 3 (NDNC3)
CC       [MIM:151600]: A nail disorder characterized by a white appearance
CC       of the nail plate (true leukonychia), the nail bed
CC       (pseudoleukonychia), or neither (apparent leukonychia).
CC       Leukonychia may involve all of the nail (leukonychia totalis) or
CC       only part of the nail (leukonychia partialis), or can appear as
CC       one or more transverse bands (leukonychia striata) or white spots
CC       (leukonychia punctata). {ECO:0000269|PubMed:21665001}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PLCD1ID43927ch3p22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09117; AAA73567.1; -; mRNA.
DR   EMBL; AK090774; BAG52226.1; -; mRNA.
DR   EMBL; AC144536; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64507.1; -; Genomic_DNA.
DR   EMBL; BC050382; AAH50382.2; -; mRNA.
DR   CCDS; CCDS2671.1; -. [P51178-1]
DR   CCDS; CCDS46793.1; -. [P51178-2]
DR   PIR; A55943; A55943.
DR   RefSeq; NP_001124436.1; NM_001130964.1. [P51178-2]
DR   RefSeq; NP_006216.2; NM_006225.3. [P51178-1]
DR   UniGene; Hs.80776; -.
DR   ProteinModelPortal; P51178; -.
DR   SMR; P51178; -.
DR   BioGrid; 111349; 15.
DR   IntAct; P51178; 3.
DR   MINT; MINT-107564; -.
DR   STRING; 9606.ENSP00000430344; -.
DR   BindingDB; P51178; -.
DR   ChEMBL; CHEMBL3727; -.
DR   SwissLipids; SLP:000001065; -.
DR   iPTMnet; P51178; -.
DR   PhosphoSitePlus; P51178; -.
DR   SwissPalm; P51178; -.
DR   BioMuta; PLCD1; -.
DR   DMDM; 206729887; -.
DR   REPRODUCTION-2DPAGE; IPI00746030; -.
DR   EPD; P51178; -.
DR   MaxQB; P51178; -.
DR   PaxDb; P51178; -.
DR   PeptideAtlas; P51178; -.
DR   PRIDE; P51178; -.
DR   Ensembl; ENST00000334661; ENSP00000335600; ENSG00000187091. [P51178-1]
DR   Ensembl; ENST00000463876; ENSP00000430344; ENSG00000187091. [P51178-2]
DR   GeneID; 5333; -.
DR   KEGG; hsa:5333; -.
DR   UCSC; uc003chm.4; human. [P51178-1]
DR   CTD; 5333; -.
DR   DisGeNET; 5333; -.
DR   GeneCards; PLCD1; -.
DR   H-InvDB; HIX0003175; -.
DR   HGNC; HGNC:9060; PLCD1.
DR   HPA; CAB009913; -.
DR   HPA; HPA020107; -.
DR   HPA; HPA021677; -.
DR   MalaCards; PLCD1; -.
DR   MIM; 151600; phenotype.
DR   MIM; 602142; gene.
DR   neXtProt; NX_P51178; -.
DR   OpenTargets; ENSG00000187091; -.
DR   Orphanet; 2387; Leukonychia totalis.
DR   PharmGKB; PA33388; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOGENOM; HOG000006871; -.
DR   HOVERGEN; HBG053610; -.
DR   InParanoid; P51178; -.
DR   KO; K05857; -.
DR   OMA; HWVLGLR; -.
DR   OrthoDB; EOG091G02KH; -.
DR   PhylomeDB; P51178; -.
DR   TreeFam; TF313216; -.
DR   BioCyc; MetaCyc:HS07195-MONOMER; -.
DR   BRENDA; 3.1.4.11; 2681.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   ChiTaRS; PLCD1; human.
DR   GeneWiki; PLCD1; -.
DR   GenomeRNAi; 5333; -.
DR   PRO; PR:P51178; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000187091; -.
DR   CleanEx; HS_PLCD1; -.
DR   Genevisible; P51178; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0032794; F:GTPase activating protein binding; IPI:BHF-UCL.
DR   GO; GO:0070300; F:phosphatidic acid binding; IEA:Ensembl.
DR   GO; GO:1901981; F:phosphatidylinositol phosphate binding; IEA:Ensembl.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR028391; PLC-delta1.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF126; PTHR10336:SF126; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Disease mutation;
KW   Glycoprotein; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transducer.
FT   CHAIN         1    756       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase delta-1.
FT                                /FTId=PRO_0000088504.
FT   DOMAIN       21    130       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      140    175       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      176    211       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      296    440       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      492    609       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      616    720       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   CA_BIND     153    164       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     189    200       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REGION       30     57       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    311    311       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    356    356       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   METAL       312    312       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       341    341       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       343    343       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       390    390       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       651    651       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       653    653       Calcium 2. {ECO:0000250}.
FT   METAL       677    677       Calcium 2. {ECO:0000250}.
FT   METAL       706    706       Calcium 3. {ECO:0000250}.
FT   METAL       707    707       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       708    708       Calcium 3. {ECO:0000250}.
FT   BINDING     438    438       Substrate. {ECO:0000250}.
FT   BINDING     440    440       Substrate. {ECO:0000250}.
FT   BINDING     522    522       Substrate. {ECO:0000250}.
FT   BINDING     549    549       Substrate. {ECO:0000250}.
FT   MOD_RES     457    457       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8R3B1}.
FT   MOD_RES     460    460       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    191    191       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   CARBOHYD    193    193       O-linked (GlcNAc) threonine.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     11       MDSGRDFLTLH -> MQCLGIRSRSRSRELYLQERSLKVAA
FT                                LNGRRL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042919.
FT   VARIANT     209    209       T -> R (in NDNC3).
FT                                {ECO:0000269|PubMed:21665001}.
FT                                /FTId=VAR_066399.
FT   VARIANT     257    257       R -> H (in dbSNP:rs933135).
FT                                /FTId=VAR_046560.
FT   VARIANT     574    574       I -> T (in NDNC3).
FT                                {ECO:0000269|PubMed:21665001}.
FT                                /FTId=VAR_066400.
FT   CONFLICT    224    224       S -> P (in Ref. 1; AAA73567).
FT                                {ECO:0000305}.
FT   CONFLICT    264    264       A -> T (in Ref. 1; AAA73567).
FT                                {ECO:0000305}.
FT   CONFLICT    591    591       G -> D (in Ref. 1; AAA73567).
FT                                {ECO:0000305}.
SQ   SEQUENCE   756 AA;  85665 MW;  6C6FD7F89BA08C83 CRC64;
     MDSGRDFLTL HGLQDDEDLQ ALLKGSQLLK VKSSSWRRER FYKLQEDCKT IWQESRKVMR
     TPESQLFSIE DIQEVRMGHR TEGLEKFARD VPEDRCFSIV FKDQRNTLDL IAPSPADAQH
     WVLGLHKIIH HSGSMDQRQK LQHWIHSCLR KADKNKDNKM SFKELQNFLK ELNIQVDDSY
     ARKIFRECDH SQTDSLEDEE IEAFYKMLTQ RVEIDRTFAE AAGSGETLSV DQLVTFLQHQ
     QREEAAGPAL ALSLIERYEP SETAKAQRQM TKDGFLMYLL SADGSAFSLA HRRVYQDMGQ
     PLSHYLVSSS HNTYLLEDQL AGPSSTEAYI RALCKGCRCL ELDCWDGPNQ EPIIYHGYTF
     TSKILFCDVL RAIRDYAFKA SPYPVILSLE NHCTLEQQRV MARHLHAILG PMLLNRPLDG
     VTNSLPSPEQ LKGKILLKGK KLGGLLPPGG EGGPEATVVS DEDEAAEMED EAVRSRVQHK
     PKEDKLRLAQ ELSDMVIYCK SVHFGGFSSP GTPGQAFYEM ASFSENRALR LLQESGNGFV
     RHNVGHLSRI YPAGWRTDSS NYSPVEMWNG GCQIVALNFQ TPGPEMDVYQ GRFQDNGACG
     YVLKPAFLRD PNGTFNPRAL AQGPWWARKR LNIRVISGQQ LPKVNKNKNS IVDPKVTVEI
     HGVSRDVASR QTAVITNNGF NPWWDTEFAF EVVVPDLALI RFLVEDYDAS SKNDFIGQST
     IPLNSLKQGY RHVHLMSKNG DQHPSATLFV KISLQD
//
